U 0126
Latest Information Update: 17 Dec 2003
Price :
$50 *
At a glance
- Originator Unknown
- Developer Johnson & Johnson Pharmaceutical Research & Development LLC; Nonindustrial source; Nonindustrial sources
- Class Antineoplastics
- Mechanism of Action Mitogen-activated protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Stroke